These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 12630670

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The BEST study: evaluating efficacy by selected demographic subsets.
    Fernandez-Obregon A, Davis MW.
    Cutis; 2003 Feb; 71(2 Suppl):18-26. PubMed ID: 12630671
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
    Weiss JW, Shavin J, Davis M.
    Clin Ther; 2002 Oct; 24(10):1706-17. PubMed ID: 12462298
    [Abstract] [Full Text] [Related]

  • 6. Improving patient satisfaction and acne severity in patients with mild to moderate acne: the BEST study.
    Weiss J, Shavin J, Davis MW.
    Cutis; 2003 Feb; 71(2 Suppl):3-4. PubMed ID: 12630668
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N, Chalermchai T, Ophaswongse S, Udompataikul M.
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE.
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [Abstract] [Full Text] [Related]

  • 12. Implications of the BEST study.
    Shavin J, Weiss J.
    Cutis; 2003 Feb; 71(2 Suppl):35-6. PubMed ID: 12630673
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
    Webster G, Rich P, Gold MH, Mraz S, Calvarese B, Chen D.
    J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL, Shamban A, Webster G, Del Rosso J, Dover JS, Swinyer L, Stein L, Lin X, Draelos Z, Gold M, Thiboutot D.
    J Drugs Dermatol; 2013 Jun 01; 12(6):619-25. PubMed ID: 23839176
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A.
    J Drugs Dermatol; 2012 Jun 01; 11(6):714-22. PubMed ID: 22648218
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.